Boston Scientific (NYSE: BSX) today announced a catheter development and commercialization deal with Siemens Healthineers.

A minimally invasive heart procedure to correct irregular heart rhythms called catheter ablation may reduce the risk of ...

Successful catheter ablation resulted in a low risk of stroke associated with atrial fibrillation (AFib), a type of irregular ...

For older people with irregular heart rhythms who are at high risk of stroke and bleeding, standard care (including the use ...

A minimally invasive heart procedure to correct irregular heart rhythms called catheter ablation may reduce the risk of ...

For older people with irregular heart rhythms who are at high risk of stroke and bleeding, standard care (including the use ...

Rapid treatment with CeleCor Therapeutics' investigational heart-attack drug, zalunfiban, resulted in higher levels of blood flow to the heart and an approximately 21% reduction in a patient's risk of ...

Varicoceles can develop at any age but are most often detected during adolescence, when physical changes make the veins more ...

Congenital Heart Disease (CHD) is one of the most common birth defects, affecting approximately 1% of live births globally and accounting for more than 4.18 million cases in children under five1.

San Francisco, USA and Amsterdam, The Netherlands – At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health ...

Two local fire departments joined a pilot program aimed at improving communication and patient outcomes. The app, Pulsara, ...